Back to Peptides

Vesugen

Moderate Research

KED | Vascular Bioregulator Peptide

Dose 10-20 mg per day (oral capsules) or 10 mg (injectable)
Frequency Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Cycle 10-20 day cycle
Storage Oral capsules: room temperature; Lyophilized powder/reconstituted: 2-8°C refrigerated

Vesugen is a Khavinson bioregulator tripeptide developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology. Composed of three amino acids (lysine, glutamic acid, aspartic acid), it targets the vascular system and protects blood vessels from age-related decline. Research shows it limits atherosclerosis development, decreases endothelial dysfunction, and activates stem cells. Like other short Khavinson peptides, Vesugen penetrates to the nucleus where it influences gene expression.

Mechanism of Action

Vesugen works through epigenetic regulation by interacting with DNA promoter regions, particularly affecting Ki-67 gene expression which controls cell division. It plays a prominent role in regulating sirtuin 1 (SIRT1) protein levels - a key anti-aging protein activated during calorie restriction. Vesugen enhances mesenchymal stem cell proliferation, reduces senescence markers, improves cell differentiation, and may reverse the Senescence-Associated Secretory Phenotype (SASP) implicated in age-related cardiovascular disease.

Key Benefits

  • Protects vascular system from aging effects
  • Limits atherosclerosis development
  • Decreases endothelial cell dysfunction
  • Activates SIRT1 anti-aging pathway
  • Enhances stem cell proliferation
  • Reduces cellular senescence markers
  • Reverses SASP phenotype
  • Works synergistically with Cardiogen
Molecular Weight
390 Da
Chain Length
3 amino acids
Type
Tripeptide bioregulator
Amino Acid Sequence
One-letter: KED
H₂N
K 1
O ‖ C
N
E 2
O ‖ C
N
D 3
COOH
Lys
1

Lysine

Position 1

Glu
2

Glutamic Acid

Position 2

Asp
3

Aspartic Acid

Position 3

N-terminus C-terminus
Hydrophobic
Polar
Positive (+)
Negative (-)
Modified

Vascular Health

  • Vascular Aging

    Protects blood vessels from age-related deterioration through gene expression regulation.

  • Atherosclerosis Prevention

    Limits development of atherosclerotic plaques in blood vessels.

  • Endothelial Function

    Decreases endothelial dysfunction that contributes to cardiovascular disease.

Anti-Aging

  • SIRT1 Activation

    Regulates sirtuin 1 levels, mimicking some benefits of calorie restriction.

  • Stem Cell Activation

    Enhances mesenchymal stem cell proliferation and reduces senescence.

  • Cellular Rejuvenation

    Reverses senescence-associated secretory phenotype in aging cells.

Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.

GoalDoseFrequencyRoute
Standard protocol10-20 mgDaily for 10-20 daysOral capsules
Maintenance10 mg2-3 cycles yearlyOral capsules
Cardiogen

Complementary cardiovascular bioregulators - Vesugen for vessels, Cardiogen for heart tissue.

synergistic
Epitalon

Often combined in comprehensive anti-aging Khavinson protocols.

synergistic
Thymalin

Different organ targets; can be used in comprehensive bioregulator protocols.

compatible
Pinealon

Part of Khavinson bioregulator family; targets different tissue.

compatible
During cycle

Gene expression modulation and SIRT1 activation begins

Post-cycle

Effects persist due to epigenetic changes

Months

Vascular function improvements

Long-term

Cumulative benefits with periodic cycles

Common Side Effects

  • Generally well-tolerated
  • Minimal side effects reported

Stop Signs - Discontinue if:

  • Allergic reactions
  • Unusual cardiovascular symptoms

Contraindications

  • Active cardiovascular emergencies (seek medical care)
  • Known hypersensitivity
  • Pregnancy or breastfeeding

Good Signs

  • White powder or capsules
  • Clear solution if reconstituted
  • Proper packaging and labeling

Warning Signs

  • Unknown source or purity

Bad Signs

  • Discoloration
  • Unusual odor
  • Damaged packaging
  • Khavinson Peptide Bioregulators Research
    Advances in Gerontology (2020)

    Comprehensive review of bioregulator peptides including Vesugen and their epigenetic mechanisms.

  • Short Peptides and Vascular Aging
    Bulletin of Experimental Biology and Medicine (2018)

    Short peptides regulate sirtuin 1 levels and protect vascular tissue from aging.

  • Mesenchymal Stem Cell Activation by Peptide Bioregulators
    Cell Technologies in Biology and Medicine (2019)

    Vesugen enhances MSC proliferation and reduces senescence markers in stem cells.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.